Conor Medsystems Purchases Assets of Phytogen Life Sciences
22nd Nov 2005, 19:56 GMT
Conor Medsystems has purchased substantially all of the assets of Phytogen Life Sciences including its inventory of finished paclitaxel, for approximately $3.8 mln.
Conor Medsystems Purchases Assets of Phytogen Life Sciences related news:
- Conor Medsystems buys Phytogen assets, ends royalties — Latest news from Silicon Valley/San Jose Business Journal
- Xanthus Life Sciences to Present at the Lazard Capital Markets Life Sciences Conference — Radiology News from StratCenter.com
- Advanced Life Sciences to Present at Lazard Capital Markets Life Sciences Conference — Bio-Technology News from StratCenter.com
- Goldman Sachs looks at 'difficult' assets of Equitable Life — Business
- Health, life-science campus gains speed — azcentral.com | glendale
- Life sciences short of workers, threatened by rivals — bizjournals.com Health Care:Biotechnology headlines
- Welcome Jeri Kemple to the Life Sciences Blogs — Telemedicine Insider
- Welcome, Heather Craven, to the Life Sciences blogs! — The Cardio Blog
- ABIOMED to Present at Lazard Life Sciences Conference — Financial News News from StratCenter.com
- Depomed to Present at the Lazard Annual Life Sciences Conference — Operations-Related News from StratCenter.com
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease